Z-1075-2025 Class II Ongoing
FDA device recall Z-1075-2025 was initiated by Oxoid Limited on Dec 23, 2024 and is designated Class II. Reason for recall: Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs. The recall status is ongoing. Affected quantity: 1406 units.
Recall details
- Product Type
- Devices
- Report Date
- Feb 12, 2025
- Initiation Date
- Dec 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1406 units
Product description
Reason for recall
Distribution pattern
US: VA, CA, NE, MA, FL, CA, MA, NH, WA OUS: Austria, Australia, Brazil, Canada, China, Costa Rica, Germany, Spain, France, United Kingdom, Ghana, Hong Kong, South Korea, Netherlands, Peru, Philippines, Poland, Indonesia
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1075-2025
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Oxoid Limited? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.